117 related articles for article (PubMed ID: 38660677)
1. Development and validation of an interpretable radiomic signature for preoperative estimation of tumor mutational burden in lung adenocarcinoma.
Zhang Y; Yang Y; Ma Y; Liu Y; Ye Z
Front Genet; 2024; 15():1367434. PubMed ID: 38660677
[TBL] [Abstract][Full Text] [Related]
2. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
[TBL] [Abstract][Full Text] [Related]
3. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
[TBL] [Abstract][Full Text] [Related]
4. Decoding tumor mutation burden and driver mutations in early stage lung adenocarcinoma using CT-based radiomics signature.
Wang X; Kong C; Xu W; Yang S; Shi D; Zhang J; Du M; Wang S; Bai Y; Zhang T; Chen Z; Ma Z; Wang J; Dong G; Sun M; Yin R; Chen F
Thorac Cancer; 2019 Oct; 10(10):1904-1912. PubMed ID: 31414580
[TBL] [Abstract][Full Text] [Related]
5. Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study.
Tang X; Qian WL; Yan WF; Pang T; Gong YL; Yang ZG
BMC Cancer; 2021 Jul; 21(1):823. PubMed ID: 34271855
[TBL] [Abstract][Full Text] [Related]
6. Establishing a predictive model for tumor mutation burden status based on CT radiomics and clinical features of non-small cell lung cancer patients.
Yang J; Shi W; Yang Z; Yu H; Wang M; Wei Y; Wen J; Zheng W; Zhang P; Zhao W; Chen L
Transl Lung Cancer Res; 2023 Apr; 12(4):808-823. PubMed ID: 37197623
[TBL] [Abstract][Full Text] [Related]
7. A machine learning-based radiomics model for prediction of tumor mutation burden in gastric cancer.
Ma T; Zhang Y; Zhao M; Wang L; Wang H; Ye Z
Front Genet; 2023; 14():1283090. PubMed ID: 38028587
[No Abstract] [Full Text] [Related]
8. MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.
Lv Y; Huang Z; Lin Y; Fang Y; Chen Z; Pan L; Zhang Y; Xu Z
Oncoimmunology; 2019; 8(10):e1629260. PubMed ID: 31646073
[No Abstract] [Full Text] [Related]
9. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
10. A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer.
Lee H; Moon SH; Hong JY; Lee J; Hyun SH
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568657
[TBL] [Abstract][Full Text] [Related]
11. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
12. CT-Imaging Based Analysis of Invasive Lung Adenocarcinoma Presenting as Ground Glass Nodules Using Peri- and Intra-nodular Radiomic Features.
Wu L; Gao C; Xiang P; Zheng S; Pang P; Xu M
Front Oncol; 2020; 10():838. PubMed ID: 32537436
[No Abstract] [Full Text] [Related]
13. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
14. Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker.
He B; Dong D; She Y; Zhou C; Fang M; Zhu Y; Zhang H; Huang Z; Jiang T; Tian J; Chen C
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636239
[TBL] [Abstract][Full Text] [Related]
15. Radiomic-Based Quantitative CT Analysis of Pure Ground-Glass Nodules to Predict the Invasiveness of Lung Adenocarcinoma.
Xu F; Zhu W; Shen Y; Wang J; Xu R; Qutesh C; Song L; Gan Y; Pu C; Hu H
Front Oncol; 2020; 10():872. PubMed ID: 32850301
[No Abstract] [Full Text] [Related]
16. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
17. The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma.
Liu Q; Huang Y; Chen H; Liu Y; Liang R; Zeng Q
BMC Cancer; 2020 Jun; 20(1):533. PubMed ID: 32513144
[TBL] [Abstract][Full Text] [Related]
18. Framework for Machine Learning of CT and PET Radiomics to Predict Local Failure after Radiotherapy in Locally Advanced Head and Neck Cancers.
Devakumar D; Sunny G; Sasidharan BK; Bowen SR; Nadaraj A; Jeyseelan L; Mathew M; Irodi A; Isiah R; Pavamani S; John S; T Thomas HM
J Med Phys; 2021; 46(3):181-188. PubMed ID: 34703102
[TBL] [Abstract][Full Text] [Related]
19. Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact.
Jiang Y; Che S; Ma S; Liu X; Guo Y; Liu A; Li G; Li Z
Cancer Imaging; 2021 Jan; 21(1):1. PubMed ID: 33407884
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Contrast-Enhanced CT-Based Deep Transfer Learning and Combined Clinical-Radiomics Model to Discriminate Thymomas and Thymic Cysts: A Multicenter Study.
Yang Y; Cheng J; Peng Z; Yi L; Lin Z; He A; Jin M; Cui C; Liu Y; Zhong Q; Zuo M
Acad Radiol; 2024 Apr; 31(4):1615-1628. PubMed ID: 37949702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
